The drug berberine was found to ameliorate NAFLD in rats through the AMPK/SIRT3 pathway, indicating that this axis plays an important role in NAFLD [367]. The gene discussed is PRKAA2; the disease is metabolic dysfunction-associated steatotic liver disease.